By contrast, the NSMP/L1CAM-negative patients were mainly ER/PR-positive and ARID1A-negative, and showed an intermediate prognosis, likely attributable to a more favorable underlying tumor biology. The gene discussed is ARID1A; the disease is neoplasm.